Table II.
ESP | R2 | MSP | R2 | LSP | R2 | |
---|---|---|---|---|---|---|
Fertile | ||||||
LE | CXCL14, CALCA | 0.40 | LIF, CALCA | 0.48 | CXCL14, CALCA | 0.67 |
CLCL14, HOXA10 | 0.41 | HBEGF, HOXA10 | −0.33 | PGR-B, HOXA10 | 0.58 | |
GE | PGR-B, CALCA | 0.40 | CXCL14, CALCA | 0.52 | PGR-B, HOXA10 | 0.62 |
PAEP, HOXA10 | 0.63 | PAEP, HOXA10 | 0.43 | |||
PAEP, HBEGF | −0.34 | |||||
STR | CALCA HOXA10 | 0.61 | ||||
Infertile | ||||||
LE | LIF, PGR-B | 0.46 | LIF, HOXA10 | 0.35 | ||
GE | HBEGF, CALCA | 0.49 | ||||
STR | CXCL14, CALCA | −0.51 | LIF, PAEP | 0.34 | LIF, PAEP | –0.46 |
LIF, HOXA10 | 0.38 | CXCL14, CALCA | 0.47 | |||
LIF, PGR-B | 0.36 | |||||
HOXA10, PGR-B | 0.38 |
Trend analysis was performed with Pearson's correlation test for each protein separately by tissue feature, cycle phase and fertility status. Proteins that were significantly correlated are shown together with the corresponding Pearson's correlation coefficient. CXCL14; chemokine ligand 14; CALCA, calcitonin; LIF, leukemia inhibitory factor; HBEGF, heparin-binding EGF-like growth factor; HOXA10, homeobox A10; PGR-B, progesterone receptor-B; PAEP, progestagen-associated endometrial protein.